Design Therapeutics, Inc (DSGN): SCHEDULE 13G filed Jun 9, 2026

Form type

SCHEDULE 13G

Filing date

Jun 9, 2026

Accession number

0000919574-26-003921

Filer

Design Therapeutics, Inc (CIK 1807120)